These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25013471)

  • 1. Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer.
    Kim SC; Kim MK; Kim YH; Ahn SA; Kim KH; Kim K; Kim WK; Lee JH; Cho JY; Yoo BC
    Oncol Lett; 2014 Aug; 8(2):566-574. PubMed ID: 25013471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.
    Lee JH; Kim YH; Kim KH; Cho JY; Woo SM; Yoo BC; Kim SC
    Cancer Res Treat; 2018 Jul; 50(3):883-893. PubMed ID: 28934848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
    Lee JH; Yoo BC; Kim YH; Ahn SA; Yeo SG; Cho JY; Kim KH; Kim SC
    BioData Min; 2016; 9():32. PubMed ID: 27752286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-mass-ion discriminant equation: a new concept for colorectal cancer screening.
    Lee JH; Kim KH; Park JW; Chang HJ; Kim BC; Kim SY; Kim KG; Lee ES; Kim DY; Oh JH; Yoo BC; Kim IH
    Int J Cancer; 2014 Apr; 134(8):1844-53. PubMed ID: 24096867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare.
    Lee JH; Yu SE; Kim KH; Yu MH; Jeong IH; Cho JY; Park SJ; Lee WJ; Han SS; Kim TH; Hong EK; Woo SM; Yoo BC
    EPMA J; 2018 Sep; 9(3):287-297. PubMed ID: 30174764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI-TOF Mass Spectrometry Based on Parylene-Matrix Chip for the Analysis of Lysophosphatidylcholine in Sepsis Patient Sera.
    Park JM; Noh JY; Kim MJ; Yun TG; Lee SG; Chung KS; Lee EH; Shin MH; Ku NS; Yoon S; Kang MJ; Park MS; Pyun JC
    Anal Chem; 2019 Nov; 91(22):14719-14727. PubMed ID: 31621295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.
    Tamir A; Gangadharan A; Balwani S; Tanaka T; Patel U; Hassan A; Benke S; Agas A; D'Agostino J; Shin D; Yoon S; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2016 Mar; 9():20. PubMed ID: 27036110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling.
    Yoo BC; Kong SY; Jang SG; Kim KH; Ahn SA; Park WS; Park S; Yun T; Eom HS
    BMC Cancer; 2010 Feb; 10():55. PubMed ID: 20175931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hypoxanthine and phosphoenolpyruvic Acid as serum markers of chemoradiotherapy response in locally advanced rectal cancer.
    Kim K; Yeo SG; Yoo BC
    Cancer Res Treat; 2015 Jan; 47(1):78-89. PubMed ID: 25143052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans.
    Park CW; Jo Y; Jo EJ
    Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling.
    Longuespée R; Boyon C; Castellier C; Jacquet A; Desmons A; Kerdraon O; Vinatier D; Fournier I; Day R; Salzet M
    Histochem Cell Biol; 2012 Jul; 138(1):141-54. PubMed ID: 22532226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
    Tiss A; Timms JF; Smith C; Devetyarov D; Gentry-Maharaj A; Camuzeaux S; Burford B; Nouretdinov I; Ford J; Luo Z; Jacobs I; Menon U; Gammerman A; Cramer R
    Int J Gynecol Cancer; 2010 Dec; 20(9):1518-24. PubMed ID: 21370595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric screening of ovarian cancer with serum glycans.
    Kim JH; Park CW; Um D; Baek KH; Jo Y; An H; Kim Y; Kim TJ
    Dis Markers; 2014; 2014():634289. PubMed ID: 24648610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip.
    Park JM; Kim MJ; Noh JY; Yun TG; Kang MJ; Lee SG; Yoo BC; Pyun JC
    J Am Soc Mass Spectrom; 2020 Apr; 31(4):917-926. PubMed ID: 32154716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven low-mass ions in pretreatment serum as potential predictive markers of the chemoradiotherapy response of rectal cancer.
    Roh K; Yeo SG; Yoo BC; Kim KH; Kim SY; Kim MJ
    Anticancer Drugs; 2016 Sep; 27(8):787-93. PubMed ID: 27272410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predict ovarian cancer by pairing serum miRNAs: Construct of single sample classifiers.
    Hong G; Luo F; Chen Z; Ma L; Lin G; Wu T; Li N; Cai H; Hu T; Zhong H; Guo Y; Li H
    Front Med (Lausanne); 2022; 9():923275. PubMed ID: 35983098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced levels of N'-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival.
    Kim KH; Joo J; Park B; Park SJ; Lee WJ; Han SS; Kim TH; Hong EK; Woo SM; Yoo BC
    Oncotarget; 2017 Dec; 8(68):112598-112609. PubMed ID: 29348849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
    Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.
    Ye B; Cramer DW; Skates SJ; Gygi SP; Pratomo V; Fu L; Horick NK; Licklider LJ; Schorge JO; Berkowitz RS; Mok SC
    Clin Cancer Res; 2003 Aug; 9(8):2904-11. PubMed ID: 12912935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.